Imperial College London

Dr Benjamin Mullish

Faculty of MedicineDepartment of Metabolism, Digestion and Reproduction

NIHR Clinical Lecturer
 
 
 
//

Contact

 

b.mullish

 
 
//

Location

 

Queen Elizabeth the Queen Mother Wing (QEQM)St Mary's Campus

//

Summary

 

Publications

Publication Type
Year
to

170 results found

Michael DR, Jack AA, Masetti G, Davies TS, Loxley KE, Kerry-Smith J, Plummer JF, Marchesi JR, Mullish BH, McDonald JAK, Hughes TR, Wang D, Garaiova I, Paduchová Z, Muchová J, Good MA, Plummer SFet al., 2020, A randomised controlled study shows supplementation of overweight and obese adults with lactobacilli and bifidobacteria reduces bodyweight and improves well-being, Scientific Reports, Vol: 10

Journal article

Ovadia C, Perdones-Montero A, Fan HM, Mullish BH, McDonald JAK, Papacleovoulou G, Wahlström A, Ståhlman M, Tsakmaki A, Clarke LCD, Sklavounos A, Dixon PH, Bewick GA, Walters JRF, Marschall H-U, Marchesi JR, Williamson Cet al., 2020, Ursodeoxycholic acid enriches intestinal bile salt hydrolase-expressing Bacteroidetes in cholestatic pregnancy, Scientific Reports, Vol: 10

Journal article

Martinez-Gili L, McDonald JAK, Liu Z, Kao D, Allegretti JR, Monaghan TM, Barker GF, Miguéns Blanco J, Williams HRT, Holmes E, Thursz MR, Marchesi JR, Mullish BHet al., 2020, Understanding the mechanisms of efficacy of fecal microbiota transplant in treating recurrent Clostridioides difficile infection and beyond: the contribution of gut microbial-derived metabolites, Gut Microbes, Vol: 12, Pages: 1810531-1810531, ISSN: 1949-0976

Journal article

Ghani R, Mullish BH, 2020, Decision – Considerations for use of fecal microbiota transplantation in special patient populations, The 6 Ds of FMT: A Primer for Clinicians from Decision to Discharge and Beyond, Editors: Allegretti, Kassam, Publisher: Slack Inc, ISBN: 9781630917500

Book chapter

Mullish BH, 2020, FMT for the Treatment of Obesity, Metabolic Syndrome and NAFLD, The 6 Ds of FMT: A Primer for Clinicians from Decision to Discharge and Beyond, Editors: Allegretti, Kassam, ISBN: 9781630917500

Book chapter

Gupta S, Mullish BH, Allegretti JR, 2020, Fecal Microbiota Transplantation: The Evolving Risk Landscape, American Journal of Gastroenterology, ISSN: 0002-9270

Journal article

Alexander JL, Mullish BH, 2020, A Guide to the Gut Microbiome and its Relevance to Critical Care, British Journal of Nursing, Vol: 29, Pages: 1106-1112, ISSN: 0966-0461

<jats:p> Although it is well-established that particular bacteria may cause gastroenteritis and other infections when present in the gut, it is only recently that scientists have made significant inroads into understanding the huge number of other bacteria and additional microbes that live within the gastrointestinal tract, referred to as the gut microbiome. In particular, it is now recognised that bacteria within the gut microbiome have a wide variety of roles in maintaining different aspects of human health, and that disturbances of these bacteria may potentially cause or contribute to a number of different medical conditions, including particular infections, certain cancers, and chronic conditions, including inflammatory bowel disease. Moreover, there is increasing awareness that these bacteria help determine how the body responds to medication, including antibiotics and chemotherapy. There has been growing interest in different approaches to alter the gut microbiome as a novel approach to medical therapy. This article provides an overview of the importance of the gut microbiome, with a particular focus on critical care. </jats:p>

Journal article

Forlano R, Mullish BH, Mukherjee SK, Nathwani R, Harlow C, Crook P, Judge R, Soubieres A, Middleton P, Daunt A, Perez-Guzman P, Selvapatt N, Lemoine M, Dhar A, Thursz MR, Nayagam S, Manousou Pet al., 2020, In-hospital mortality is associated with inflammatory response in NAFLD patients admitted for COVID-19, PLOS ONE, Vol: 15, Pages: e0240400-e0240400

Journal article

Allegretti JR, Kelly CR, Grinspan A, Mullish BH, Hurtado J, Carrellas M, Marcus J, Marchesi JR, McDonald JAK, Gerardin Y, Silverstein M, Pechlivanis A, Barker GF, Miguens Blanco J, Alexander JL, Gallagher KI, Pettee W, Phelps E, Nemes S, Sagi SV, Bohm M, Kassam Z, Fischer Met al., 2020, Inflammatory Bowel Disease Outcomes Following Fecal Microbiota Transplantation for Recurrent C. difficile Infection, Inflammatory Bowel Diseases, ISSN: 1078-0998

Journal article

Forlano R, Mullish B, Mukherjee S, Nathwani R, Harlow C, Crook P, Judge R, Soubieres A, Middleton P, Daunt A, Perez Guzman P, Selvapatt N, Lemoine M, Dhar A, Thursz MR, Nayagam S, Manousou Pet al., 2020, 450 - In-hospital mortality is associated with inflammatory response in NAFLD patients admitted for COVID-19, Hepatology, Vol: 72, Pages: 282A-283A, ISSN: 0270-9139

Journal article

Forlano R, Mullish BH, Maurice JB, Thursz MR, Goldin RD, Manousou Pet al., 2020, NAFLD: Time to apply quantitation in liver biopsies as endpoints in clinical trials, Journal of Hepatology, ISSN: 0168-8278

Journal article

Allegretti JR, Kelly C, Grinspan AM, Mullish BH, Hurtado J, Nemes S, Sagi S, Bohm M, Kassam Z, Fischer Met al., 2020, S0650 Fecal Microbiota Transplantation Decolonizes C. difficile in Patients With Inflammatory Bowel Disease and Concomitant C. difficile Infection, Publisher: Ovid Technologies (Wolters Kluwer Health), Pages: S326-S326, ISSN: 0002-9270

Conference paper

Craven LJ, McIlroy JR, Mullish BH, Marchesi JRet al., 2020, Letter: Intestinal Microbiota Transfer – Updating the Nomenclature to Increase Acceptability, Alimentary Pharmacology and Therapeutics, ISSN: 0269-2813

Journal article

Miguens Blanco J, Selvarajah U, Liu Z, Mullish BH, Alexander J, McDonald J, Abraham S, Marchesi Jet al., 2020, Identification of New Associations Between Psoriatic Arthritis and the Gut Microbiota. the Mi-PART, a Phenomic Study, ACR Convergence 2020, Publisher: Wiley, ISSN: 2326-5205

Conference paper

Ianiro G, Mullish BH, Kelly CR, Kassam Z, Kuijper EJ, Ng SC, Iqbal TH, Allegretti JR, Bibbò S, Sokol H, Zhang F, Fischer M, Costello SP, Keller JJ, Masucci L, van Prehn J, Quaranta G, Quraishi MN, Segal J, Kao D, Satokari R, Sanguinetti M, Tilg H, Gasbarrini A, Cammarota Get al., 2020, Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic, Gut, Vol: 69, Pages: 1555-1563, ISSN: 0017-5749

<jats:p>The COVID-19 pandemic has led to an exponential increase in SARS-CoV-2 infections and associated deaths, and represents a significant challenge to healthcare professionals and facilities. Individual countries have taken several prevention and containment actions to control the spread of infection, including measures to guarantee safety of both healthcare professionals and patients who are at increased risk of infection from COVID-19. Faecal microbiota transplantation (FMT) has a well-established role in the treatment of <jats:italic>Clostridioides difficile</jats:italic> infection. In the time of the pandemic, FMT centres and stool banks are required to adopt a workflow that continues to ensure reliable patient access to FMT while maintaining safety and quality of procedures. In this position paper, based on the best available evidence, worldwide FMT experts provide guidance on issues relating to the impact of COVID-19 on FMT, including patient selection, donor recruitment and selection, stool manufacturing, FMT procedures, patient follow-up and research activities.</jats:p>

Journal article

McIlroy JR, Mullish BH, Goldenberg SD, Ianiro G, Marchesi JRet al., 2020, Intestinal microbiome transfer, a novel therapeutic strategy for COVID-19 induced hyperinflammation?, Clinical Immunology, Vol: 218, Pages: 108542-108542, ISSN: 1521-6616

Journal article

Segal JP, Mullish BH, Quraishi MN, Iqbal THet al., 2020, Letter: faecal microbiota transplantation for IBS, Alimentary Pharmacology & Therapeutics, Vol: 52, Pages: 556-557, ISSN: 0269-2813

Journal article

Nathwani R, Mukherjee S, Forlano R, Mullish BH, Vergis N, Selvapatt N, Manousou P, Nayagam S, Lemoine M, Dhar Aet al., 2020, Letter: liver disease and COVID-19-not the perfect storm, Alimentary Pharmacology & Therapeutics, Vol: 52, Pages: 572-574, ISSN: 0269-2813

Journal article

Woodhouse C, Edwards L, Mullish BH, Kronsten V, Tranah T, Zamalloa A, Flach C, Douiri A, Marchesi J, Patel V, Goldenberg S, Shawcross DLet al., 2020, Results of the PROFIT trial, a PROspective randomised placebo-controlled feasibility trial of Faecal mIcrobiota Transplantation in advanced cirrhosis, Publisher: Elsevier BV, Pages: S77-S78, ISSN: 0168-8278

Conference paper

Smith PJ, 2020, GI highlights from the literature, Gut, Vol: 69, Pages: 1533-1534, ISSN: 0017-5749

Journal article

Forlano R, Mullish BH, Giannakeas N, Maurice JB, Angkathunyakul N, Lloyd J, Tzallas AT, Tsipouras M, Yee M, Thursz MR, Goldin RD, Manousou Pet al., 2020, High-Throughput, Machine Learning–Based Quantification of Steatosis, Inflammation, Ballooning, and Fibrosis in Biopsies From Patients With Nonalcoholic Fatty Liver Disease, Clinical Gastroenterology and Hepatology, Vol: 18, Pages: 2081-2090.e9, ISSN: 1542-3565

Journal article

Ianiro G, Segal JP, Mullish BH, Quraishi MN, Porcari S, Fabiani G, Gasbarrini A, Cammarota Get al., 2020, Fecal microbiota transplantation in gastrointestinal and extraintestinal disorders, Future Microbiology, ISSN: 1746-0913

Journal article

Ghani R, Mullish BH, McDonald JAK, Ghazy A, Williams HRT, Brannigan ET, Mookerjee S, Satta G, Gilchrist M, Duncan N, Corbett R, Innes AJ, Pavlů J, Thursz MR, Davies F, Marchesi JRet al., 2020, Disease Prevention Not Decolonization: A Model for Fecal Microbiota Transplantation in Patients Colonized With Multidrug-resistant Organisms, Clinical Infectious Diseases, ISSN: 1058-4838

<jats:title>Abstract</jats:title> <jats:p>Fecal microbiota transplantation (FMT) yields variable intestinal decolonization results for multidrug-resistant organisms (MDROs). This study showed significant reductions in antibiotic duration, bacteremia, and length of stay in 20 patients colonized/infected with MDRO receiving FMT (compared with pre-FMT history, and a matched group not receiving FMT), despite modest decolonization rates.</jats:p>

Journal article

Allegretti JR, Kelly CR, Grinspan A, Mullish BH, Kassam Z, Fischer Met al., 2020, Outcomes of Fecal Microbiota Transplantation in Patients With Inflammatory Bowel Diseases and Recurrent Clostridioides difficile Infection, Gastroenterology, ISSN: 0016-5085

Journal article

Ianiro G, Mullish BH, Kelley CR, 2020, Correction to Lancet Gastroenterol Hepatol 2020; 5: 430-31, LANCET GASTROENTEROLOGY & HEPATOLOGY, Vol: 5, Pages: E5-E5

Journal article

Blanco JM, Liu Z, Selvarajah U, Mullish BH, Alexander JL, McDonald JA, Abraham S, Marchesi Jet al., 2020, Sa1923 IDENTIFICATION OF NEW ASSOCIATIONS BETWEEN PSORIATIC ARTHRITIS AND THE GUT MICROBIOTA, A PHENOMIC STUDY, Gastroenterology, Vol: 158, Pages: S-481, ISSN: 0016-5085

Journal article

Allegretti JR, Kassam Z, Hurtado J, Carrellas M, Marchesi J, Mullish BH, Chiang AL, Cummings BP, Thompson CCet al., 2020, Tu1909 IMPACT OF FECAL MICROBIOTA TRANSPLANTATION ON PREVENTION OF METABOLIC SYNDROME AMONG PATIENTS WITH OBESITY, Gastroenterology, Vol: 158, ISSN: 0016-5085

Journal article

Ghani R, Mullish BH, McDonald JA, Ghazy A, Williams HR, Brannigan E, Satta G, Gilchrist M, Duncan N, Corbett R, Pavlu J, Innes AJ, Thursz MR, Davies F, Marchesi Jet al., 2020, 1144 FECAL MICROBIOTA TRANSPLANT FOR MULTI-DRUG RESISTANT ORGANISMS: IMPROVED CLINICAL OUTCOMES BEYOND INTESTINAL DECOLONISATION, Gastroenterology, Vol: 158, ISSN: 0016-5085

Journal article

Martinez-Gili L, McDonald JA, Liu Z, Kao DH, Allegretti JR, Barker GF, Blanco JM, Holmes E, Thursz MR, Marchesi J, Mullish BHet al., 2020, 644 IDENTIFICATION OF NOVEL CHANGES IN MICROBIALLY-DERIVED METABOLITES AFTER FECAL MICROBIOTA TRANSPLANT FOR RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION, Publisher: Elsevier BV, ISSN: 0016-5085

Conference paper

Allegretti JR, Hurtado J, Carrellas M, Marcus J, Nemes S, Marchesi J, Mullish BH, McDonald JA, Phelps EL, Sagi S, Bohm M, Geradin Y, Silverstein M, Kelly CR, Kassam Z, Grinspan A, Fischer Met al., 2020, 121 ULCERATIVE COLITIS PATIENTS ACHEIVE MORE ROBUST ENGRAFTMENT COMPARED TO PATIENTS WITH CROHN'S DISEASE AFTER FECAL MICROBIOTA TRANSPLANTATION FOR THE TREATMENT OF RECURRENT C. DIFFICLE INFECTION, Gastroenterology, Vol: 158, Pages: S-22, ISSN: 0016-5085

Journal article

This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.

Request URL: http://wlsprd.imperial.ac.uk:80/respub/WEB-INF/jsp/search-html.jsp Request URI: /respub/WEB-INF/jsp/search-html.jsp Query String: id=00350833&limit=30&person=true&page=1&respub-action=search.html